TD Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-596,600
Closed -$32.2M 1440
2023
Q1
$32.2M Hold
596,600
0.04% 339
2022
Q4
$31.4M Hold
596,600
0.04% 340
2022
Q3
$28.5M Hold
596,600
0.04% 342
2022
Q2
$30.1M Hold
596,600
0.03% 342
2022
Q1
$36.4M Sell
596,600
-19,581
-3% -$1.17M 0.03% 351
2021
Q4
$40.6M Buy
616,181
+786
+0.1% +$50.3K 0.03% 361
2021
Q3
$38.6M Sell
615,395
-2,001,115
-76% -$128M 0.04% 334
2021
Q2
$27.8M Buy
2,616,510
+1,684,236
+181% +$97.4M 0.03% 410
2021
Q1
$51.3M Buy
932,274
+756
+0.1% +$41.9K 0.06% 267
2020
Q4
$50.8M Buy
931,518
+4,404
+0.5% +$230K 0.06% 242
2020
Q3
$46.3M Buy
927,114
+228,822
+33% +$11.1M 0.06% 231
2020
Q2
$30.8M Buy
698,292
+607,674
+671% +$26M 0.04% 276
2020
Q1
$3.4M Sell
90,618
-17,298
-16% -$728K 0.01% 709
2019
Q4
$4.75M Buy
+107,916
New +$4.54M 0.01% 721

Other funds holding IHI

TD Asset Management's IHI Position: Q2 2023 in Review

TD Asset Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2023, closing a stake of 596,600 shares — an estimated $32.2M sold.

TD Asset Management first reported a position in IHI in Q4 2019 and held it in 14 quarters. The position peaked at $51.3M in Q1 2021. 585 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • TD Asset Management reported no remaining iShares US Medical Devices ETF position as of Q2 2023 after selling out during the quarter.
  • TD Asset Management sold 596,600 iShares US Medical Devices ETF shares in Q2 2023, an estimated $32.2M.
  • TD Asset Management first reported a position in iShares US Medical Devices ETF in Q4 2019 and held it in 14 quarters.
  • TD Asset Management's iShares US Medical Devices ETF position peaked at $51.3M in Q1 2021.
  • 585 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.